Journal Information
Most Often Read
3061
A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countriesPatrizia Pignatti, Dina Visca, Stelios Loukides, Anne-Grete Märtson, Jan-Willem C. Alffenaar, Giovanni Battista Migliori, Antonio Spanevello
Pulmonol. 2022;28:44-58
3061
Open access
2708
Molecular analysis in cytological samples obtained by endobronchial or oesophageal ultrasound guided needle aspiration in non-small cell lung cancerC. Centeno, P. Serra Mitja, M. Avila, E. Carcereny, A.M. Muñoz-Mármol, T. Moran, E. Castellà, J. Sanz-Santos, I. García Olivé, J.L. Ramirez Serrano, A. Rosell Gratacos, F. Andreo García
Pulmonol. 2022;28:28-33
2708
Open access
2659
COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICUMaría Laura Vega, Roberto Dongilli, Gustavo Olaizola, Nicolás Colaianni, Mauro Castro Sayat, Lara Pisani, Micaela Romagnoli, Greta Spoladore, Irene Prediletto, Guillermo Montiel, Stefano Nava
Pulmonol. 2022;28:13-7
2659
Open access
1937
Severe asthma in the era of COVID-19: A narrative reviewJoão Gaspar-Marques, Mafalda van Zeller, Pedro Carreiro-Martins, Cláudia Chaves Loureiro
Pulmonol. 2022;28:34-43
1937
Open access
1295
The COVID-19 impact on the scientific production on the 25 main death causes according to world regionFelipe Eduardo Valencise, Matheus Negri Boschiero, Camila Vantini Capasso Palamim, Fernando Augusto Lima Marson
Pulmonol. 2022;28:1-3
1295
Open access
1184
SARS-CoV-2 as a trigger of eosinophilic pneumoniaM. Araújo, S. Correia, A.L. Lima, M. Costa, I. Neves
Pulmonol. 2022;28:62-4
1184
Open access
1019
First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary diseaseK. Fukushima, K. Akagi, A. Kondo, T. Kubo, N. Sakamoto, H. Mukae
Pulmonol. 2022;28:6-12
1019
Open access
964
Pulmonary function tests: The patient´s perspectiveMarta Carvalho Silva, Inês Ladeira, Ricardo Lima, Miguel Guimarães
Pulmonol. 2022;28:73-5
964
Open access
882
Practice of tracheostomy in patients with acute respiratory failure related to COVID–19 – Insights from the PRoVENT–COVID studyA.M. Tsonas, M. Botta, J. Horn, M.J. Brenner, M.S. Teng, B.A. McGrath, M.J. Schultz, F. Paulus, A. Serpa Neto
Pulmonol. 2022;28:18-27
882
Open access
860
Differences in exercise capacity and health-related quality of life according to the body mass index in patients with COPDJhonatan Betancourt-Peña, Juan Carlos Ávila-Valencia, Diana Milena Diaz-Vidal, Vicente Benavides-Córdoba
Pulmonol. 2022;28:70-2
860
Open access
Special content about COVID-19
- SARS-CoV-2 as a trigger of eosinophilic pneumonia
- The COVID-19 impact on the scientific production on the 25 main death causes according to world region
- Outcomes of COVID-19 patients treated with noninvasive respiratory support outside-ICU setting: a Portuguese reality
- COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
